Applicant, as named in the Orange Book

Karyopharm Theraps

Next listed expiry: Xpovio on 14 Aug 2035. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Xpovio · 6 strengths selinexor	selinexor	212306	14 Aug 2035	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.